The decision marks a strategic shift in PHC Holdings' portfolio, refocusing its efforts in other areas of its business.
PHC Holdings announced its plan to transfer its continuous glucose monitoring system business, signaling a strategic pivot in its operations. The move reflects a broader shift in the company’s portfolio strategy, with a focus on realigning its resources and business priorities.